In Reply.—Dr Sepkowitz primarily proposes
that a large fraction of our case reports of postvaccinal hair loss might
have been received after April 1994, when the index patient's experience was
publicized in California. If so, he implies, the apparently large number of
case reports would more likely reflect only "background" coincidental events,
rather than a pathophysiologic linkage between vaccination and subsequent
loss of hair.
In the first 6 weeks after publication of our article, we were interviewed
by a half-dozen journalists, and secondary publicity appeared. Concomitant
with and presumably on account of the fanfare, we have learned of an additional
6 patients with hair loss after vaccinations. This high reporting rate, averaging
1 new case per week, displays the publicity effect precisely as we related
with respect to our index case and illustrates the problem that concerns Sepkowitz.
* * SCHEDULED MAINTENANCE * *
Our websites may be periodically unavailable between midnight and 04:00 ET Thursday, July 10th, for regularly scheduled maintenance.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.